ARTICLE | Company News
Texas Biotech and Icos form joint venture
June 6, 2000 7:00 AM UTC
The companies formed an equally-owned joint venture, called Icos-Texas Biotechnology LP, to develop and market endothelin-A receptor antagonists to treat various diseases, including essential and pulm...